— Know what they know.
Not Investment Advice
Also trades as: 0HBQ.L (LSE) · $vol 0M · AK3.F (FSX) · $vol 0M · AK3.DE (XETRA) · $vol 0M

AKAM NASDAQ

Akamai Technologies, Inc.
1W: -4.4% 1M: +3.6% 3M: -3.4% YTD: +28.0% 1Y: +43.6% 3Y: +1.8% 5Y: -1.1%
$108.92
+1.99 (+1.86%)
 
Weekly Expected Move ±8.7%
$90 $99 $109 $118 $128
NASDAQ · Technology · Software - Infrastructure · Tech Score Neutral · Power 53 · $15.8B mcap · 142M float · 2.94% daily turnover · Short 57% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.7 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 3.9%  ·  5Y Avg: 11.1%
Cost Advantage
52
Intangibles
47
Switching Cost
59
Network Effect
42
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AKAM shows a Weak competitive edge (50.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 3.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$123
Low
$153
Avg Target
$225
High
Based on 9 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 25Hold: 25Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$152.18
Analysts11
Consensus Change History
DateFieldFromTo
2026-09-02 consensus Hold Buy
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-29 Raymond James Frank Louthan $140 $170 +30 +56.0% $108.99
2026-09-28 D.A. Davidson Rudy Kessinger $185 $150 -35 +32.4% $113.33
2026-09-25 Piper Sandler — $125 $158 +33 +43.1% $110.41
2026-09-25 Guggenheim John DiFucci $128 $225 +97 +103.8% $110.41
2026-09-25 UBS Roger Boyd $125 $148 +23 +34.0% $110.41
2026-08-31 Piper Sandler — $97 $125 +28 +15.1% $108.62
2026-08-10 HSBC Stephen Bersey $121 $123 +2 +11.3% $110.54
2026-08-07 Robert W. Baird — $150 $140 -10 +22.9% $113.88
2026-08-07 RBC Capital — $100 $135 +35 +17.5% $114.89
2026-07-29 UBS Roger Boyd $160 $125 -35 +11.8% $111.79
2026-07-27 Evercore ISI Peter Levine $165 $175 +10 +54.5% $113.30
2026-05-14 Morgan Stanley Sanjit Singh $120 $165 +45 +2.4% $161.14
2026-05-11 Susquehanna Shyam Patil $120 $175 +55 +18.5% $147.71
2026-05-08 Scotiabank Patrick Colville $120 $180 +60 +26.8% $141.92
2026-05-08 UBS — $110 $160 +50 +13.1% $141.46
2026-05-08 Robert W. Baird — $110 $150 +40 +6.9% $140.30
2026-05-08 Oppenheimer — $115 $180 +65 +27.9% $140.73
2026-05-08 D.A. Davidson — $125 $185 +60 +36.7% $135.29
2026-05-08 Raymond James — $120 $140 +20 +3.0% $135.93
2026-05-08 Evercore ISI — $115 $165 +50 +23.6% $133.50
2026-05-08 Craig-Hallum — $125 $190 +65 +62.8% $116.69
2026-05-08 KeyBanc Jackson Ader $120 $195 +75 +67.1% $116.69
2026-03-12 Raymond James Frank Louthan $100 $120 +20 +13.8% $105.47
2026-02-23 Raymond James Frank Louthan Initiated $100 — +1.0% $99.03
2026-02-23 Goldman Sachs — Initiated $76 — -19.3% $94.17
2026-02-23 Piper Sandler — $89 $97 +8 +3.0% $94.17
2026-02-20 Scotiabank Patrick Colville $105 $120 +15 +20.7% $99.42
2026-02-20 Susquehanna — $135 $120 -15 +21.3% $98.89
2026-02-20 Evercore ISI — Initiated $115 — +15.9% $99.27
2026-02-20 Robert W. Baird — $115 $110 -5 +0.4% $109.59
2026-02-20 UBS Roger Boyd Initiated $110 — +0.4% $109.59
2026-02-20 KeyBanc — $115 $120 +5 +9.5% $109.59
2026-02-20 Morgan Stanley Sanjit Singh $115 $120 +5 +9.5% $109.59
2026-02-05 Oppenheimer — $100 $115 +15 +24.1% $92.68
2026-01-12 Morgan Stanley — $85 $115 +30 +30.5% $88.12
2026-01-09 Scotiabank — $115 $105 -10 +20.2% $87.36
2026-01-05 Piper Sandler James Fish $83 $89 +6 +4.6% $85.10
2025-12-15 KeyBanc Jackson Ader $119 $115 -4 +33.9% $85.89
2025-11-17 Oppenheimer — Initiated $100 — +14.7% $87.17
2025-08-08 Piper Sandler James Fish $112 $83 -29 +17.7% $70.53
2025-08-05 Morgan Stanley — $90 $85 -5 +15.4% $73.65
2025-04-16 Morgan Stanley Keith Weiss $102 $90 -12 +21.9% $73.81
2024-11-11 Robert W. Baird William Power $135 $115 -20 +13.8% $101.02
2024-11-11 HSBC Stephen Bersey $96 $121 +25 +19.8% $101.02
2024-08-09 Craig-Hallum Jeff Van Rhee Initiated $125 — +36.5% $91.57
2024-08-09 Scotiabank Patrick Colville $110 $115 +5 +25.6% $91.57
2024-08-09 RBC Capital Mark Mahaney $110 $100 -10 +9.2% $91.57
2024-07-28 Guggenheim Raymond McDonough $75 $128 +53 +32.0% $96.97
2024-07-24 HSBC Stephen Bersey Initiated $96 — -0.4% $96.37
2024-07-15 Piper Sandler James Fish $114 $112 -2 +17.7% $95.14

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
4
ROE
3
ROA
3
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. AKAM receives an overall rating of B. Strongest factors: DCF (4/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-09-25 B- B
2026-09-24 B B-
2026-08-20 B- B
2026-08-18 B B-
2026-05-26 B+ B
2026-05-08 A- B+
2026-05-06 B+ A-
2026-04-06 B B+
2026-04-02 B+ B
2026-04-01 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 44 Grade C
Profitability
37
Balance Sheet
55
Earnings Quality
62
Growth
41
Value
32
Momentum
72
Safety
50
Cash Flow
51
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AKAM scores highest in Momentum (72/100) and lowest in Value (32/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.94
Grey Zone
Piotroski F-Score
3/9
✓ ✓ ✗ ✓ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
-2.58
Unlikely Manipulator
Ohlson O-Score
-7.17
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 55.3/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 3.52x
Accruals: -8.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AKAM scores 1.94, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AKAM scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AKAM's score of -2.58 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AKAM's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AKAM receives an estimated rating of BBB (score: 55.3/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). AKAM's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
38.35x
PEG
-54.84x
P/S
3.66x
P/B
3.32x
P/FCF
28.84x
P/OCF
12.55x
EV/EBITDA
18.78x
EV/Revenue
5.59x
EV/EBIT
43.30x
EV/FCF
38.34x
Earnings Yield
2.26%
FCF Yield
3.47%
Shareholder Yield
7.79%
Graham Number
$43.12
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 38.4x earnings, AKAM commands a growth premium. Graham's intrinsic value formula yields $43.12 per share, 153% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.823
NI / EBT
×
Interest Burden
0.895
EBT / EBIT
×
EBIT Margin
0.129
EBIT / Rev
×
Asset Turnover
0.338
Rev / Assets
×
Equity Multiplier
2.779
Assets / Equity
=
ROE
8.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AKAM's ROE of 8.9% is driven by Asset Turnover (0.338), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$22.73
Price/Value
5.20x
Margin of Safety
-420.07%
Premium
420.07%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with AKAM's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. AKAM trades at a 420% premium to its adjusted intrinsic value of $22.73, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 38.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$108.92
Median 1Y
$105.23
5th Pctile
$58.58
95th Pctile
$189.48
Ann. Volatility
36.9%
Analyst Target
$152.18
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Dr. Leighton
Chief Executive Officer
$1 $15,954,171 $15,954,172
Mr. Karon Manager
General Manager of the Cloud Technology Group
$570,000 $7,146,594 $7,725,594
Mr. McGowan EVP,
Chief Financial Officer and Treasurer
$535,000 $5,657,142 $6,198,315
Mr. Sundaram EVP
and General Manager, Security Technology Group
$500,000 $4,933,327 $5,442,327
Mr. Joseph EVP,
Global Sales and Services
$520,000 $4,799,712 $5,328,712

CEO Pay Ratio

143:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $15,954,172
Avg Employee Cost (SGA/emp): $111,913
Employees: 11,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
11,000
+2.8% YoY
Revenue / Employee
$382,561
Rev: $4,208,175,000
Profit / Employee
$41,094
NI: $452,031,000
SGA / Employee
$111,913
Avg labor cost proxy
R&D / Employee
$46,687
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 13.9% 14.8% 14.6% 13.9% 12.6% 12.9% 12.6% 12.3% 13.2% 12.2% 14.2% 13.9% 11.5% 10.7% 9.8% 9.2% 10.6% 9.2% 9.2% 8.9% 8.92%
ROA 7.7% 8.2% 7.8% 7.6% 6.8% 7.0% 6.5% 6.4% 6.4% 6.0% 6.9% 6.8% 5.3% 5.0% 4.5% 4.1% 4.8% 4.1% 4.0% 3.2% 3.21%
ROIC 12.1% 11.3% 9.9% 9.7% 9.1% 9.2% 8.1% 7.8% 7.1% 6.5% 7.9% 7.5% 6.2% 5.8% 5.2% 4.6% 4.9% 4.4% 4.7% 3.9% 3.93%
ROCE 10.1% 10.9% 10.5% 10.1% 9.5% 8.9% 8.6% 8.2% 7.2% 7.4% 8.1% 9.3% 7.9% 7.4% 7.5% 6.1% 7.3% 6.4% 5.7% 4.6% 4.56%
Gross Margin 63.2% 64.1% 63.2% 61.6% 60.7% 61.4% 60.5% 60.1% 60.3% 60.5% 60.0% 58.9% 59.3% 59.4% 58.7% 59.1% 59.3% 54.6% 56.1% 55.8% 55.81%
Operating Margin 23.9% 21.7% 19.2% 19.4% 18.2% 18.1% 13.8% 16.0% 18.2% 18.6% 16.9% 15.1% 7.0% 14.5% 15.2% 14.5% 15.7% 13.8% 10.7% 7.3% 7.30%
Net Margin 20.8% 17.7% 14.8% 15.3% 14.0% 19.1% 10.6% 13.8% 16.6% 16.2% 17.8% 13.4% 5.8% 13.7% 12.1% 9.9% 13.3% 7.8% 9.9% 7.2% 7.22%
EBITDA Margin 40.9% 37.7% 33.9% 36.0% 35.2% 34.3% 28.9% 31.1% 34.3% 35.6% 35.6% 33.7% 24.3% 33.2% 34.9% 32.0% 36.8% 28.0% 27.7% 26.8% 26.79%
FCF Margin 20.7% 24.8% 24.6% 24.2% 24.0% 22.6% 20.3% 19.2% 15.9% 16.2% 20.2% 22.0% 22.9% 20.9% 17.7% 16.6% 17.4% 16.6% 17.9% 14.6% 14.57%
OCF Margin 38.5% 40.6% 39.1% 37.5% 36.7% 35.2% 35.4% 35.8% 34.7% 35.4% 37.8% 39.0% 39.4% 38.1% 35.3% 35.4% 36.2% 36.1% 37.0% 33.5% 33.48%
ROE 3Y Avg snapshot only 10.46%
ROE 5Y Avg snapshot only 11.58%
ROA 3Y Avg snapshot only 4.33%
ROIC 3Y Avg snapshot only 7.21%
ROIC Economic snapshot only 3.01%
Cash ROA snapshot only 9.60%
Cash ROIC snapshot only 13.48%
CROIC snapshot only 5.87%
NOPAT Margin snapshot only 9.76%
Pretax Margin snapshot only 11.55%
R&D / Revenue snapshot only 12.83%
SGA / Revenue snapshot only 31.16%
SBC / Revenue snapshot only 11.79%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 28.78 29.63 31.04 24.19 23.00 23.22 22.83 26.20 29.31 33.94 27.36 22.00 29.69 29.00 26.86 27.28 21.98 28.37 39.59 44.21 38.352
P/S Ratio 5.11 5.58 5.55 4.13 3.55 3.67 3.37 3.77 4.41 4.88 4.41 3.52 3.94 3.67 3.03 2.84 2.70 3.05 4.04 4.20 3.663
P/B Ratio 3.80 4.26 4.54 3.45 3.02 3.04 2.93 3.22 3.82 4.04 3.70 2.91 3.26 3.00 2.65 2.59 2.35 2.58 3.51 3.83 3.318
P/FCF 24.65 22.47 22.58 17.07 14.81 16.26 16.60 19.61 27.81 30.05 21.81 16.04 17.20 17.56 17.10 17.06 15.51 18.34 22.53 28.84 28.842
P/OCF 13.29 13.74 14.19 11.02 9.68 10.41 9.51 10.52 12.69 13.78 11.68 9.03 9.99 9.64 8.57 8.01 7.45 8.44 10.90 12.55 12.553
EV/EBITDA 14.27 15.61 16.62 13.07 11.74 12.17 12.06 13.74 16.65 17.92 15.07 12.29 14.51 13.98 12.20 12.50 11.39 13.42 16.73 18.78 18.778
EV/Revenue 5.39 6.09 6.32 4.84 4.19 4.24 4.05 4.45 5.36 5.84 5.16 4.28 4.68 4.43 3.85 3.89 3.89 4.41 5.20 5.59 5.587
EV/EBIT 24.51 26.34 28.62 23.08 21.60 22.98 23.21 26.67 31.68 33.15 27.17 22.22 28.47 28.70 25.72 27.04 22.36 27.55 36.53 43.30 43.302
EV/FCF 25.96 24.54 25.74 20.00 17.46 18.79 19.96 23.15 33.81 35.99 25.50 19.49 20.45 21.20 21.74 23.40 22.41 26.52 28.99 38.34 38.342
Earnings Yield 3.5% 3.4% 3.2% 4.1% 4.3% 4.3% 4.4% 3.8% 3.4% 2.9% 3.7% 4.5% 3.4% 3.4% 3.7% 3.7% 4.6% 3.5% 2.5% 2.3% 2.26%
FCF Yield 4.1% 4.5% 4.4% 5.9% 6.8% 6.2% 6.0% 5.1% 3.6% 3.3% 4.6% 6.2% 5.8% 5.7% 5.8% 5.9% 6.4% 5.5% 4.4% 3.5% 3.47%
Price/Tangible Book snapshot only 18.512
EV/OCF snapshot only 16.688
EV/Gross Profit snapshot only 9.904
Acquirers Multiple snapshot only 47.157
Shareholder Yield snapshot only 7.79%
Graham Number snapshot only $43.12
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.78 2.43 1.68 1.92 2.25 2.41 2.03 2.00 2.30 2.16 3.25 1.32 1.33 1.23 1.18 2.31 2.28 2.29 1.99 1.64 1.637
Quick Ratio 3.78 2.43 1.68 1.92 2.25 2.41 2.03 2.00 2.30 2.16 3.25 1.32 1.33 1.23 1.18 2.31 2.28 2.29 1.99 1.64 1.637
Debt/Equity 0.62 0.63 0.75 0.75 0.74 0.73 0.77 0.77 1.04 0.99 0.99 0.97 0.97 0.95 1.01 1.18 1.28 1.39 1.20 1.97 1.967
Net Debt/Equity 0.20 0.39 0.64 0.59 0.54 0.47 0.59 0.58 0.82 0.80 0.63 0.63 0.62 0.62 0.72 0.96 1.05 1.15 1.01 1.26 1.260
Debt/Assets 0.35 0.35 0.39 0.39 0.39 0.38 0.39 0.39 0.47 0.46 0.46 0.46 0.46 0.45 0.46 0.50 0.56 0.60 0.50 0.62 0.620
Debt/EBITDA 2.22 2.12 2.42 2.43 2.46 2.52 2.65 2.77 3.73 3.65 3.44 3.37 3.63 3.67 3.64 4.15 4.30 5.00 4.43 7.26 7.261
Net Debt/EBITDA 0.72 1.32 2.04 1.91 1.78 1.64 2.03 2.10 2.96 2.96 2.18 2.18 2.30 2.40 2.60 3.39 3.51 4.14 3.73 4.65 4.652
Interest Coverage 10.48 11.07 13.56 17.72 25.89 59.04 57.15 54.01 46.91 37.91 33.73 29.65 23.93 22.72 22.22 22.26 12.52 9.52 10.89 9.51 9.514
Equity Multiplier 1.77 1.80 1.93 1.92 1.92 1.90 1.96 1.95 2.22 2.15 2.14 2.12 2.13 2.13 2.18 2.36 2.29 2.31 2.37 3.17 3.174
Cash Ratio snapshot only 1.181
Debt Service Coverage snapshot only 21.939
Cash to Debt snapshot only 0.359
FCF to Debt snapshot only 0.067
Defensive Interval snapshot only 816.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.42 0.42 0.43 0.43 0.40 0.39 0.40 0.40 0.39 0.39 0.39 0.34 0.338
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 5.27 5.18 5.08 5.39 5.61 5.34 5.09 5.36 5.61 5.43 5.46 5.62 5.63 5.50 5.45 5.52 5.65 5.53 5.20 4.99 4.990
Payables Turnover 11.70 11.11 10.69 11.74 12.43 10.84 8.69 8.82 11.20 10.34 9.17 9.87 12.74 11.69 11.32 12.31 11.39 13.87 11.87 8.97 8.973
DSO 69 70 72 68 65 68 72 68 65 67 67 65 65 66 67 66 65 66 70 73 73.1 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 31 33 34 31 29 34 42 41 33 35 40 37 29 31 32 30 32 26 31 41 40.7 days
Cash Conversion Cycle 38 38 38 37 36 35 30 27 32 32 27 28 36 35 35 36 33 40 39 32 32.5 days
Fixed Asset Turnover snapshot only 0.999
Cash Velocity snapshot only 1.288
Capital Intensity snapshot only 3.487
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 8.9% 8.2% 7.5% 7.1% 5.6% 4.5% 3.0% 2.5% 4.2% 5.4% 7.0% 7.3% 5.9% 4.7% 3.5% 4.0% 4.2% 5.4% 6.2% 5.9% 5.87%
Net Income 7.4% 17.0% 6.7% 4.5% -8.1% -12.3% -14.9% -13.8% 1.4% -4.2% 16.9% 19.4% -6.6% -7.8% -27.7% -32.5% -3.7% -10.5% -3.9% -3.2% -3.21%
EPS 7.5% 17.6% 8.1% 7.5% -3.9% -8.1% -10.8% -9.2% 4.1% -4.0% 15.9% 19.3% -6.5% -5.4% -24.6% -28.6% 1.4% -6.7% -3.2% -8.5% -8.52%
FCF 38.9% 77.9% 54.4% 42.9% 22.3% -5.0% -14.9% -18.7% -31.2% -24.3% 6.6% 22.7% 53.0% 34.8% -9.5% -21.3% -20.9% -16.1% 7.6% -7.2% -7.22%
EBITDA 11.5% 16.1% 10.8% 7.1% -0.1% -6.7% -9.0% -10.5% -6.1% -1.4% 9.0% 15.4% 6.2% 1.8% -4.6% -7.1% 10.4% 9.3% 4.6% 1.2% 1.22%
Op. Income 9.5% 18.9% 12.4% 7.5% -2.3% -13.6% -18.7% -19.4% -12.0% -5.8% 7.6% 11.8% -8.0% -16.3% -23.1% -22.3% 8.8% 16.9% 11.9% -2.4% -2.40%
OCF Growth snapshot only 0.04%
Asset Growth snapshot only 43.06%
Equity Growth snapshot only 6.29%
Debt Growth snapshot only 77.17%
Shares Change snapshot only 5.81%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 8.5% 8.4% 8.6% 8.5% 8.2% 7.7% 7.1% 6.4% 6.2% 6.0% 5.8% 5.6% 5.2% 4.9% 4.5% 4.6% 4.8% 5.2% 5.5% 5.7% 5.69%
Revenue 5Y 8.1% 8.1% 8.2% 8.2% 8.0% 7.7% 7.2% 6.9% 7.0% 7.0% 7.1% 7.0% 6.9% 6.6% 6.4% 6.1% 5.8% 5.6% 5.4% 5.3% 5.33%
EPS 3Y 39.8% 29.6% 21.7% 13.8% 8.3% 7.6% 4.3% 1.4% 2.5% 1.3% 3.8% 5.2% -2.2% -5.8% -8.0% -8.2% -0.4% -5.4% -5.4% -8.0% -7.97%
EPS 5Y 15.3% 17.0% 16.4% 17.0% 15.9% 23.7% 25.0% 26.9% 22.3% 14.0% 13.2% 9.8% 4.3% 2.5% -0.1% -2.3% 0.4% -1.7% -4.0% -5.3% -5.31%
Net Income 3Y 39.3% 29.7% 21.4% 13.1% 7.0% 6.1% 2.7% -1.0% 0.0% -0.6% 2.0% 2.5% -4.5% -8.2% -10.4% -11.4% -3.0% -7.5% -6.7% -7.9% -7.92%
Net Income 5Y 14.1% 15.6% 14.8% 15.4% 14.1% 21.7% 22.6% 24.0% 20.3% 12.9% 12.2% 8.3% 3.0% 1.1% -1.7% -4.8% -2.1% -4.1% -5.9% -6.8% -6.79%
EBITDA 3Y 21.9% 18.1% 14.4% 10.7% 8.5% 7.2% 5.4% 2.2% 1.5% 2.2% 3.2% 3.4% -0.1% -2.2% -1.8% -1.4% 3.3% 3.1% 2.8% 2.8% 2.77%
EBITDA 5Y 9.5% 10.7% 10.6% 10.9% 10.4% 12.4% 12.3% 12.1% 11.2% 8.6% 8.2% 7.0% 5.0% 4.3% 4.0% 2.8% 4.2% 3.5% 1.8% 0.8% 0.78%
Gross Profit 3Y 7.7% 7.6% 7.5% 7.2% 6.4% 5.4% 4.6% 3.7% 3.7% 3.7% 3.6% 3.5% 3.2% 2.6% 2.2% 2.4% 2.9% 2.9% 3.3% 3.1% 3.15%
Gross Profit 5Y 7.5% 7.4% 7.5% 7.4% 7.0% 6.7% 6.0% 5.6% 5.6% 5.5% 5.5% 5.2% 4.9% 4.5% 4.2% 3.9% 3.7% 3.4% 3.0% 2.8% 2.83%
Op. Income 3Y 38.8% 29.3% 21.8% 13.9% 9.7% 7.2% 3.6% -0.9% -2.0% -1.1% -0.5% -1.1% -7.6% -12.0% -12.3% -11.2% -4.2% -2.7% -2.5% -5.4% -5.37%
Op. Income 5Y 9.5% 11.2% 11.4% 12.0% 11.7% 16.9% 18.2% 19.8% 18.1% 11.9% 9.6% 5.9% 1.3% -0.6% -1.7% -3.3% -1.2% -1.1% -3.3% -6.0% -5.99%
FCF 3Y 10.4% 12.6% 16.9% 13.2% 18.7% 18.1% 14.9% 13.6% 5.3% 8.6% 11.9% 12.5% 8.8% -1.0% -6.3% -7.8% -5.9% -5.0% 1.3% -3.6% -3.61%
FCF 5Y 3.8% 9.2% 11.8% 13.6% 16.5% 16.1% 12.2% 11.0% 2.5% 0.5% 7.7% 7.7% 11.9% 10.9% 7.9% 7.2% 7.2% 7.7% 6.4% 0.8% 0.79%
OCF 3Y 12.5% 11.7% 12.1% 7.6% 7.5% 6.4% 4.7% 6.0% 2.6% 3.5% 5.7% 5.1% 6.1% 2.6% 1.0% 2.6% 4.3% 6.0% 7.1% 3.4% 3.36%
OCF 5Y 7.6% 10.1% 10.9% 10.9% 10.9% 9.7% 8.6% 9.2% 7.2% 6.0% 8.5% 7.3% 8.1% 7.5% 4.8% 5.6% 4.4% 4.6% 4.9% 1.8% 1.84%
Assets 3Y 14.8% 14.2% 17.0% 15.4% 8.4% 5.8% 5.6% 4.9% 8.4% 8.4% 8.3% 8.4% 7.9% 8.4% 6.3% 8.7% 10.1% 11.4% 12.5% 21.8% 21.78%
Assets 5Y 13.3% 13.2% 13.3% 12.8% 12.4% 12.5% 11.8% 8.3% 12.3% 12.6% 13.9% 13.6% 9.9% 8.2% 7.5% 7.8% 7.6% 8.1% 8.3% 13.7% 13.73%
Equity 3Y 13.2% 12.4% 9.4% 8.0% 6.5% 6.0% 4.3% 3.2% 1.7% 2.6% 2.4% 2.0% 1.5% 2.5% 2.2% 1.4% 3.8% 4.5% 5.6% 3.4% 3.45%
Book Value 3Y 13.6% 12.3% 9.7% 8.8% 7.7% 7.5% 6.0% 5.7% 4.2% 4.5% 4.1% 4.8% 4.0% 5.1% 4.9% 5.1% 6.5% 6.9% 7.0% 3.4% 3.40%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.98 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.99 1.00 0.99 0.99 0.993
Earnings Stability 0.74 0.83 0.83 0.81 0.77 0.84 0.74 0.61 0.60 0.51 0.61 0.52 0.11 0.00 0.02 0.15 0.64 0.62 0.58 0.56 0.561
Margin Stability 0.99 0.99 0.98 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.97 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.96 0.957
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.97 0.93 0.97 0.98 0.97 0.95 0.94 0.94 0.99 0.98 0.93 0.92 0.97 0.97 0.89 0.87 0.99 0.96 0.98 0.99 0.987
Earnings Smoothness 0.93 0.84 0.93 0.96 0.92 0.87 0.84 0.85 0.99 0.96 0.84 0.82 0.93 0.92 0.68 0.61 0.96 0.89 0.96 0.97 0.967
ROE Trend -0.00 0.01 0.01 0.01 -0.00 -0.01 -0.01 -0.01 -0.00 -0.02 -0.00 -0.00 -0.02 -0.02 -0.03 -0.03 -0.01 -0.02 -0.03 -0.03 -0.027
Gross Margin Trend -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.02 -0.02 -0.03 -0.031
FCF Margin Trend 0.04 0.09 0.08 0.07 0.06 0.03 -0.01 -0.02 -0.07 -0.07 -0.02 0.00 0.03 0.01 -0.03 -0.04 -0.02 -0.02 -0.01 -0.05 -0.047
Sustainable Growth Rate 13.9% 14.8% 14.6% 13.9% 12.6% 12.9% 12.6% 12.3% 13.2% 12.2% 14.2% 13.9% 11.5% 10.7% 9.8% 9.2% 10.6% 9.2% 9.2% 8.9% 8.92%
Internal Growth Rate 8.4% 8.9% 8.5% 8.2% 7.4% 7.5% 6.9% 6.8% 6.8% 6.4% 7.4% 7.3% 5.6% 5.2% 4.8% 4.3% 5.1% 4.3% 4.2% 3.3% 3.32%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.17 2.16 2.19 2.20 2.38 2.23 2.40 2.49 2.31 2.46 2.34 2.44 2.97 3.01 3.13 3.41 2.95 3.36 3.63 3.52 3.521
FCF/OCF 0.54 0.61 0.63 0.65 0.65 0.64 0.57 0.54 0.46 0.46 0.54 0.56 0.58 0.55 0.50 0.47 0.48 0.46 0.48 0.44 0.435
FCF/Net Income snapshot only 1.533
OCF/EBITDA snapshot only 1.125
CapEx/Revenue 17.7% 15.8% 14.5% 13.3% 12.7% 12.7% 15.1% 16.6% 18.9% 19.2% 17.6% 17.0% 16.5% 17.2% 17.6% 18.8% 18.8% 19.5% 19.1% 18.9% 18.91%
CapEx/Depreciation snapshot only 1.122
Accruals Ratio -0.09 -0.09 -0.09 -0.09 -0.09 -0.09 -0.09 -0.09 -0.08 -0.09 -0.09 -0.10 -0.11 -0.10 -0.10 -0.10 -0.09 -0.10 -0.11 -0.08 -0.081
Sloan Accruals snapshot only -0.006
Cash Flow Adequacy snapshot only 1.771
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 53.6% 80.1% 90.1% 1.0% 1.3% 1.1% 1.6% 1.6% 1.4% 1.2% 68.8% 67.0% 90.1% 1.1% 2.1% 2.6% 3.4% 3.5% 3.0% 3.4% 3.44%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.9% 2.7% 2.9% 4.3% 5.5% 4.6% 7.0% 6.0% 4.7% 3.5% 2.5% 3.0% 3.0% 3.8% 7.7% 9.5% 15.6% 12.5% 7.6% 7.8% 7.79%
Net Buyback Yield 1.9% 2.7% 2.9% 4.3% 5.5% 4.6% 7.0% 6.0% 4.7% 3.5% 2.5% 3.0% 3.0% 3.8% 7.7% 9.5% 15.6% 12.4% 7.4% 7.5% 7.52%
Total Shareholder Return 1.9% 2.7% 2.9% 4.3% 5.5% 4.6% 7.0% 6.0% 4.7% 3.5% 2.5% 3.0% 3.0% 3.8% 7.7% 9.5% 15.6% 12.4% 7.4% 7.5% 7.52%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.93 0.91 0.90 0.88 0.84 0.88 0.86 0.87 0.90 0.84 0.87 0.86 0.84 0.86 0.79 0.76 0.77 0.75 0.79 0.82 0.823
Interest Burden (EBT/EBIT) 0.87 0.89 0.90 0.93 0.95 0.97 0.99 0.99 0.99 0.97 0.97 0.97 0.96 0.95 0.95 0.95 0.91 0.89 0.91 0.89 0.895
EBIT Margin 0.22 0.23 0.22 0.21 0.19 0.18 0.17 0.17 0.17 0.18 0.19 0.19 0.16 0.15 0.15 0.14 0.17 0.16 0.14 0.13 0.129
Asset Turnover 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.44 0.42 0.42 0.43 0.43 0.40 0.39 0.40 0.40 0.39 0.39 0.39 0.34 0.338
Equity Multiplier 1.80 1.81 1.87 1.84 1.84 1.85 1.95 1.93 2.07 2.03 2.06 2.04 2.17 2.14 2.16 2.24 2.21 2.22 2.28 2.78 2.779
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $3.63 $3.95 $3.85 $3.78 $3.49 $3.63 $3.43 $3.43 $3.63 $3.49 $3.98 $4.09 $3.40 $3.30 $3.00 $2.92 $3.45 $3.08 $2.90 $2.67 $2.67
Book Value/Share $27.55 $27.46 $26.28 $26.47 $26.61 $27.69 $26.72 $27.95 $27.90 $29.28 $29.43 $30.96 $30.98 $31.87 $30.35 $30.76 $32.18 $33.87 $32.72 $30.90 $32.83
Tangible Book/Share $16.22 $12.49 $6.37 $6.43 $6.44 $7.33 $6.13 $6.54 $6.56 $7.71 $8.09 $6.35 $6.81 $6.53 $4.81 $4.28 $6.22 $7.87 $7.44 $6.39 $6.39
Revenue/Share $20.46 $20.98 $21.52 $22.09 $22.60 $22.97 $23.24 $23.86 $24.16 $24.28 $24.66 $25.57 $25.63 $26.07 $26.61 $28.11 $28.11 $28.63 $28.44 $28.13 $29.88
FCF/Share $4.24 $5.21 $5.29 $5.35 $5.42 $5.18 $4.72 $4.58 $3.83 $3.94 $4.99 $5.62 $5.87 $5.45 $4.71 $4.67 $4.89 $4.76 $5.10 $4.10 $4.35
OCF/Share $7.87 $8.52 $8.42 $8.29 $8.30 $8.10 $8.23 $8.54 $8.39 $8.59 $9.32 $9.97 $10.11 $9.92 $9.39 $9.96 $10.17 $10.33 $10.53 $9.42 $10.00
Cash/Share $11.53 $6.54 $3.10 $4.27 $5.43 $7.02 $4.82 $5.15 $6.06 $5.51 $10.64 $10.66 $10.98 $10.43 $8.75 $6.65 $7.61 $8.07 $6.20 $21.83 $23.19
EBITDA/Share $7.72 $8.19 $8.19 $8.19 $8.07 $8.00 $7.81 $7.72 $7.78 $7.91 $8.44 $8.90 $8.27 $8.26 $8.39 $8.75 $9.62 $9.40 $8.83 $8.37 $8.37
Debt/Share $17.11 $17.33 $19.83 $19.94 $19.82 $20.16 $20.67 $21.39 $29.05 $28.89 $29.04 $30.05 $30.05 $30.27 $30.57 $36.29 $41.33 $47.01 $39.11 $60.77 $60.77
Net Debt/Share $5.58 $10.80 $16.73 $15.67 $14.39 $13.14 $15.85 $16.24 $22.99 $23.38 $18.41 $19.39 $19.07 $19.84 $21.83 $29.64 $33.72 $38.93 $32.91 $38.93 $38.93
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.944
Altman Z-Prime snapshot only 3.664
Piotroski F-Score 8 7 6 6 5 5 6 6 5 4 5 4 6 6 5 7 6 6 5 3 3
Beneish M-Score -2.84 -2.84 -2.70 -2.76 -2.81 -2.83 -2.95 -2.91 -2.64 -2.68 -2.82 -2.84 -3.01 -2.97 -2.86 -2.79 -2.78 -2.77 -2.73 -2.58 -2.579
Ohlson O-Score snapshot only -7.166
ROIC (Greenblatt) snapshot only 9.09%
Net-Net WC snapshot only $-36.92
EVA snapshot only $-651516086.46
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 85.63 87.21 83.21 81.34 83.56 84.52 82.89 81.85 75.03 79.53 80.39 70.77 69.77 70.20 63.57 67.83 64.68 61.37 67.69 55.34 55.344
Credit Grade snapshot only 9
Credit Trend snapshot only -12.485
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 50
Sector Credit Rank snapshot only 37

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms